Wall Street Thinks Teva Can Soar Over 60%. Here’s Why Analysts Are Right.
Companies must evolve to stay relevant in the pharmaceutical industry. Teva Pharmaceutical Industries (TEVA -1.19%) is in the midst of its own transformation, from making generic drugs and biosimilars to novel drugs that are beginning to deliver growth and profits that are catching Wall Street’s eye. Every single Wall Street analyst polled by CNN Business…